Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ensure Medical was a medical device company focused on developing innovative solutions for vascular closure. The company's flagship product, the ExoSeal Vascular Closure Device, was designed to achieve rapid hemostasis of the femoral artery following diagnostic or interventional catheterization procedures. By utilizing a bioabsorbable polymer plug, the technology aimed to reduce complications and improve patient recovery times compared to manual compression. The device was engineered to provide a secure mechanical closure without entering the artery, minimizing the risk of intravascular complications. Ensure Medical was acquired by Cordis Corporation, a division of Johnson & Johnson, in 2006 to strengthen its portfolio in the cardiovascular intervention market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ensure Medical.